PMID- 35757136 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220716 IS - 2296-2360 (Print) IS - 2296-2360 (Electronic) IS - 2296-2360 (Linking) VI - 10 DP - 2022 TI - Morning Versus Evening Dosing of Sublingual Immunotherapy in Allergic Asthma: A Prospective Study. PG - 892572 LID - 10.3389/fped.2022.892572 [doi] LID - 892572 AB - BACKGROUND: Sublingual immunotherapy (SLIT) has been proved to be an effective and safe treatment for allergic asthma (AS) in children. Nonetheless, several issues regarding SLIT remain to be resolved, including the information about optimal administration timing. METHODS: A total of 163 AS children aged 4-13 years were enrolled and randomized into the morning dosing (MD) group and the evening dosing (ED) group. Participants received SLIT with Dermatophagoides farinae drops between 7:00 a. m. and 9:00 a.m. (for the MD group) or between 8:00 p. m. and 10:00 p.m. (for the ED group). The total asthma symptom score (TASS), total asthma medicine score (TAMS), Asthma Control Questionnaire (ACQ), forced expiratory volume in one second (FEV(1)), FEV(1)/forced volume vital capacity (FVC), fractional exhaled nitric oxide (FeNO) and adverse events (AEs) were assessed at baseline, 0.5 and 1 year during the 1-year SLIT. RESULTS: After 1 year, 62 patients in the MD group and 63 patients in the ED group completed the entire study. The clinical efficacy, pulmonary function and FeNO in both groups improved significantly at 0.5 and 1 year (p < 0.001). Compared to the MD group, the ED group showed significant lower ACQ score at 0.5 year (p < 0.001) and lower FeNO at 1 year (p < 0.05). No significant difference between two groups was observed in AE rate (p > 0.05). All AEs occurred in the first month, with no systemic AEs reported. CONCLUSION: 1-year house dust mite (HDM) SLIT is effective and well-tolerated in AS children regardless of administration time. SLIT dosing in the evening might enhance the asthma control level and reduce FeNO level compared with SLIT dosing in the morning. CI - Copyright (c) 2022 Liao, Chen, Wang, Quan, Chen and Lin. FAU - Liao, Feng AU - Liao F AD - Center for Prevention and Treatment of Pediatric Asthma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan, China. FAU - Chen, Shi AU - Chen S AD - Center for Prevention and Treatment of Pediatric Asthma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan, China. FAU - Wang, Ling AU - Wang L AD - Center for Prevention and Treatment of Pediatric Asthma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan, China. FAU - Quan, Ying-Yu AU - Quan YY AD - Center for Prevention and Treatment of Pediatric Asthma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan, China. FAU - Chen, Li-Li AU - Chen LL AD - Center for Prevention and Treatment of Pediatric Asthma, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Hainan, China. FAU - Lin, Guo-Hua AU - Lin GH AD - Respiratory Department, Geological Hospital of Hainan Province, Hainan, China. LA - eng PT - Journal Article DEP - 20220609 PL - Switzerland TA - Front Pediatr JT - Frontiers in pediatrics JID - 101615492 PMC - PMC9218255 OTO - NOTNLM OT - allergen-specific immunotherapy OT - allergic asthma OT - chronotherapy OT - house dust mite OT - sublingual immunotherapy COIS- The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. EDAT- 2022/06/28 06:00 MHDA- 2022/06/28 06:01 PMCR- 2022/06/09 CRDT- 2022/06/27 04:17 PHST- 2022/03/14 00:00 [received] PHST- 2022/05/17 00:00 [accepted] PHST- 2022/06/27 04:17 [entrez] PHST- 2022/06/28 06:00 [pubmed] PHST- 2022/06/28 06:01 [medline] PHST- 2022/06/09 00:00 [pmc-release] AID - 10.3389/fped.2022.892572 [doi] PST - epublish SO - Front Pediatr. 2022 Jun 9;10:892572. doi: 10.3389/fped.2022.892572. eCollection 2022.